GTHX - What's Going On With G1 Therapeutics Stock? | Benzinga
G1 Therapeutics, Inc. (NASDAQ:GTHX) shares are trading higher Thursday amid M&A blog speculation of a takeover offer.
What To Know:
According to a report from Seeking Alpha, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics. According to the report, one offer from TerSera is rumored to have a contingent value right which could value the company at between $12 and $14 per share.
G1 Therapeutics shares are climbing on heavy trading volume as investors digest the rumors of a possible takeover offer. According to data from ...